|
Immunotherapy Part 1: Basics of Immune-Related Adverse Events |
|
Enduring |
|
$0.00 |
|
SGO Wellness Curriculum |
|
Enduring |
|
$0.00 |
|
Keeping up with the Chemos Series: Tisotumab Vedotin - Preparing to Give It (Part 1) |
|
Enduring |
|
$0.00 |
|
ERAS Guidelines: Same Day Discharge |
|
Enduring |
|
$0.00 |
|
Front Line Ovarian Cancer: Turning Up The Heat on Immunotherapy - 2020 Annual Meeting Webinar Series |
|
Enduring |
|
$0.00 |
|
Keeping up with the Chemos Series: Mirvetuximab Soravtansine - Follow up Monitoring Between Cycles (Part 3) |
|
Enduring |
|
$0.00 |
|
Educating Your Trainee During the COVID-19 Pandemic |
|
Enduring |
|
$0.00 |
|
SGO Oncofertility Part 2: Risks of Premature Ovarian Failure |
|
Enduring |
|
$0.00 |
|
Scientific Plenary I: Breaking Barriers: Towards Greater Equity in Gyn Oncology Care |
|
Enduring |
|
$0.00 |
|
Highlights from the 2022 Annual Meeting on Women's Cancer |
|
Enduring |
|
$0.00 |
|
Keeping Up with the Chemos: Trabectedin and Doxorubicin - Administration (Part 2) |
|
Enduring |
|
$0.00 |
|
SGO 2021 Robotics Academy: Radical Hysterectomy: Mastering Advanced Robotics Surgeries |
|
Enduring |
|
$0.00 |
|
Best of ESMO 2022 Podcast |
|
Enduring |
|
$0.00 |
|
SGO Journal Club: Controversial Topics in Gynecologic Cancer: Heated Intraperitoneal Chemotherapy |
|
Enduring |
|
$0.00 |
|
SGO Late Breaking - SGO 2024 |
|
Enduring |
|
$0.00 |
Facebook
Twitter
LinkedIn
Forward